1-15 of 257
Unmet Needs in SLE: The Challenge of Achieving Sustained Disease Control
Living RheumUnmet Needs in SLE: The Challenge of Achieving Sustained Disease Control
Steve Jackson, PharmD
Maria Dall'Era, MD
Seeing Beyond Skin Scores and Rethinking Severity in Plaque Psoriasis
DermConsultSeeing Beyond Skin Scores and Rethinking Severity in Plaque Psoriasis
Charles Turck, PharmD, BCPS, BCCCP
Steve Daveluy, MD, FAAD
Connecting TYK2 Biology to Psoriasis Pathogenesis
DermConsultConnecting TYK2 Biology to Psoriasis Pathogenesis
Charles Turck, PharmD, BCPS, BCCCP
Steven R. Feldman, MD, PhD
Unmet Needs and Emerging Evidence in Severe Asthma: Two-Year Data on an Ultra-Long-Acting Biologic
Deep Breaths: Updates from CHESTUnmet Needs and Emerging Evidence in Severe Asthma: Two-Year Data on an Ultra-Long-Acting Biologic
Donna Gardner, DrPH, RRT, RRT-NPS, FAARC, FCCP
Nicola A. Hanania, MD, MS, FCCP
Recognizing and Managing Chronic Hand Eczema as a Distinct Inflammatory Disease
DermConsultRecognizing and Managing Chronic Hand Eczema as a Distinct Inflammatory Disease
Shelina Ramnarine, PhD
Firas George Hougeir, MD, FAAD
How Nasal Polyps Influence the CRS Disease Course
Clinician's RoundtableHow Nasal Polyps Influence the CRS Disease Course
Amber Luong, MD, PhD
- advertisement
Managing Chronic Rhinosinusitis With and Without Nasal Polyps
Clinician's RoundtableManaging Chronic Rhinosinusitis With and Without Nasal Polyps
Amber Luong, MD, PhD
Antifibrotics in CPFE: What Long-Term Data Reveal
Clinician's RoundtableAntifibrotics in CPFE: What Long-Term Data Reveal
Addressing Missed and Misdiagnosed COPD Cases
Clinician's RoundtableAddressing Missed and Misdiagnosed COPD Cases
Michael Schweitzer, MD
COPD Exacerbations and Opportunities for Prevention
Clinician's RoundtableCOPD Exacerbations and Opportunities for Prevention
Michael Schweitzer, MD
Aldehyde Detoxification Protects Mucociliary Clearance in Airway Defense
Clinician's RoundtableAldehyde Detoxification Protects Mucociliary Clearance in Airway Defense
Understanding CHE: Subtypes, Symptoms, and Barrier Disruption
DermConsultUnderstanding CHE: Subtypes, Symptoms, and Barrier Disruption
Christopher Bunick, MD, PhD, FAAD
- advertisement
Beyond the Symptoms: The Quality-of-Life Burden of CHE
DermConsultBeyond the Symptoms: The Quality-of-Life Burden of CHE
Christopher Bunick, MD, PhD, FAAD
Emerging Evidence in CHE: Epidemiology, Treatment, and Guidelines
DermConsultEmerging Evidence in CHE: Epidemiology, Treatment, and Guidelines
Christopher Bunick, MD, PhD, FAAD
A Comprehensive Approach to Long-Term CHE Management
DermConsultA Comprehensive Approach to Long-Term CHE Management
Christopher Bunick, MD, PhD, FAAD
